Just as patients have a stronger voice in today’s healthcare marketplace, that voice should resonate earlier in the drug development process. By adopting a patient-centric approach during protocol design and in day-to-day study management, sponsors can expect improved patient enrollment and retention, as well as a cleaner study with definitive outcomes.
In this digital age, virtual trials may very well become the norm at some point in the future, but there are many questions to answer before this can become a reality. Learn how virtual trials may be able to address patient-centricity issues while also providing the added benefit of reducing costs related to study sites.
Patient registries assist orphan drug development by giving manufacturers access to clinical, genetic, and biological data from a large patient population. Using registries, sponsors can better understand the disease, its history, and patients’ needs, all of which benefits clinical trial design and effectiveness.
The numbers vary, but multiple surveys confirm what we all know: patient recruitment is one of the most challenging and important aspects of running a clinical trial. Understand the role of a study navigator and how they help to ease patient worries and up the odds they’ll enroll — and stay enrolled — in your study.
When conducting complex dermatology clinical trials with difficult to treat, rare, or complicated skin conditions, the study’s success or failure can often hinge on the relationship between the principal investigator (PI) and patients. Learn what to look for in a dermatology study investigator.